Newsletter Subject

[INSIDER SPY ALERT] - BHVN? Hmm probably...

From

neuromastersoftware.com

Email Address

support@neuromastersoftware.com

Sent On

Fri, Jun 21, 2024 02:13 AM

Email Preheader Text

Here is what i found today: Hi , Did you get my new Insider Spy software? Seems you are not. Missing

Here is what i found today: Hi , Did you get my new Insider Spy software? Seems you are not. Missing alot on sideline. [Here is private link for you (don't share with anyone).]( The scanner found one interesting candidate today. It was on our radar since May 22nd, for 4 weeks, periodically popping up at unusual options activity panel, but never seen with direct insider buy so far. And it's happened today. Look: Mr. Bruce Car, Chief Scientific Officer, just took out of his pocket $1,007,490 cash, and bought 30,000 shares of his own company-BHVN (Biohaven Ltd.). The main scientist at the company that is in Biotechnology and Healthcare, writing the check for the amount of more than his annual income ($883.03k) to invest into it, and keep it for the next 6 months. Sounds 'suspicious' at least! :-D Here is the brief summary for BHVN: Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. Hmm okay.. Immunology and neuroscience.. Oncology.. Just curious, what are they working on right now?? - Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses. - Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity. - BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder - BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain - and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. No news on this company though. Yet. Do you think Bruce knows something we do not know? Well, he should know everything related to bioscience. And he should be the first who would know newest experiments results for brand new product, or something that would put these Phase 3 meds into FDA approved status. Even earlier than any other C-level executive. I am adding BHVN into my HOT WATCHLIST now. Want more like this? [Install Insider Spy Pro and do the same pickup within a minutes after that.]( Talk to you later! mailto:support@neuromastersoftware.com?subject=Insider%20Spy%20Pro%20expiring%20deal Trade Smart, Not Often. Konstantin (Kostya) Grek Neuromaster Software Creator. One Commerce Center, 1201 Orange St., #600 Wilmington, DE, 19899 [Unsubscribe]( | [Change Subscriber Options](

Marketing emails from neuromastersoftware.com

View More
Sent On

25/11/2024

Sent On

06/11/2024

Sent On

30/10/2024

Sent On

20/10/2024

Sent On

11/10/2024

Sent On

10/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.